Skip to content
Search

Latest Stories

NHS to invest extra £15 million to strengthen mental health support for staff

The NHS staff including pharmacists will get rapid access to expanded mental health services that are being rolled out across the country as part of efforts to deal with the second wave of Covid-19.

NHS England and NHS Improvement will invest an extra £15 million to strengthen mental health support for pharmacists, nurses, paramedics, therapists, and support staff.


Staff referred by themselves or colleagues will be rapidly assessed and treated by local expert mental health specialists. Those with the most severe needs will be referred to a specialist centre of excellence.

The investment will fund outreach work among those deemed most as risk such as critical care staff.

The £15 million investment builds on the commitments set out in the People Plan published in July. Pledges included the piloting of a series of mental health hubs around the country, offering immediate support as well as rapid access to more specialist treatment where needed.

“It is crucial that the NHS staff working tirelessly to protect the health of the nation throughout this pandemic are given the support they deserve, which is why we are announcing this expansion of services," said Claire Murdoch, NHS National Mental Health Director.

The NHS already funds NHS Practitioner Health for doctors and dentists, which provides confidential mental health and addiction services and supports over 2,500 new patients each year.

Existing mental health support for staff will also be expanded as the country moves into winter and faces a potential second wave of Covid-19. Current support services available to NHS workers include:

  • a dedicated health and care staff support service including confidential support via phone and text message.
  • a specialist bereavement support helpline for those who have lost friends and family – whether from Covid-19 or otherwise.
  • a specialist app for black, Asian and minority ethnic colleagues, Liberate, to manage anxiety and stress levels.
  • online resources, guidance and webinars.

More For You

Walgreens Boots Alliance acquired by Sycamore in deal

Walgreens Boots Alliancehas entered into “a definitive agreement” to be acquired by Sycamore Partners

Gettyimages

Walgreens Boots Alliance acquired by Sycamore in £18.3 billion deal

Walgreens Boots Alliance(WBA) has entered into “a definitive agreement” to be acquired by Sycamore Partners, a private equity firm specializing in retail, consumer and distribution-related investments.

“The total value of the transaction represents up to $23.7 billion (£18.3 billion),” the company announced late last night (6).

Keep ReadingShow less
Professor Sir Stephen Powis at a press briefing

Professor Sir Stephen Powis, was appointed national medical director of NHS England in 2018

NHS

NHS England’s top doctor to step down following Amanda Pritchard’s resignation

Just a week after NHS England chief executive Amanda Pritchard announced her resignation, the organisation’s national medical director, Professor Sir Stephen Powis, has confirmed he will step down this summer after more than seven years in the role.

In a statement released on Thursday, Professor Powis revealed that he had informed Pritchard of his intention to leave in a letter back in January.

Keep ReadingShow less
PDA calls on GP practices to use funding boost to improve job security for pharmacists

Now, it is time to focus on the community pharmacy contract

gettyimages

PDA urges GP practices to ensure funding boost supports employed pharmacists

The Pharmacists' Defence Association (PDA) has called on GP practicesto ensure that all healthcare professionals they employ, including pharmacists, benefit from the 7.2% funding boost they received under a newly agreed contract.

GP employers are encouraged to improve “job security, pay and conditions” for employees with this increased funding.

Keep ReadingShow less
Fourth Shift: Investment in Innovative Medicines Crucial for NHS 10-Year Plan Success

Medicines should be viewed as an investment rather than a cost

gettyimages

ABPI wants to see a ‘fourth shift’ in NHS 10-Year Health Plan


The Association of the British Pharmaceutical Industry (ABPI) has called on the government to increase investment in innovative medicines and vaccines, describing it as a crucial “fourth shift” necessary to ensure the NHS is fit for the future.

Keep ReadingShow less
Lawrence Tallon named new MHRA chief executive

Lawrence Tallon

Photo credit: Sciana Network

Lawrence Tallon named new MHRA chief executive

Lawrence Tallon has been appointed as the new chief executive officer of the Medicines and Healthcare products Regulatory Agency (MHRA), effective 1 April 2025.

He will succeed Dame June Raine DBE, who is retiring after leading the agency since 2019.

Keep ReadingShow less